Exploratory Laboratory and Analysis Projects in Parkinson’s Disease Biomarkers (U18)
Funding Contact(s): Katrina Gwinn, M.D.
Funding Categories: Neurodegeneration, Neurogenetics
Brief Description:
The purpose of this funding opportunity announcement (FOA) is to stimulate innovation and development of technologies and
reagents that will accelerate the discovery of biological biomarkers for Parkinson’s disease (PD). It is expected that the
NINDS Parkinson’s disease biomarkers program (PDBP) will consolidate, integrate and enhance NINDS-funded PD biomarkers research
projects. This FOA will foster research into biospecimen preparation methodologies, quantitative analyte analysis, reagent
and assay development, and data analysis methods needed for PD biomarkers progress to occur. Utilization of extant specimens
and data for novel discovery projects is permitted under this FOA, as long as consent enables deposition of all data into
the PDBP Data Management Resource (DMR).